vinorelbine tartrate

News alerts, weekly reports and conference planners

Company:

Generic mfg.

Drug class:

Tubulin polymerization inhibitor

Related drugs:

No biomarker	Peritoneal Cancer	No biomarker	Peritoneal Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Nasopharyngeal Carcinoma	No biomarker	Nasopharyngeal Carcinoma	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Sarcoma	No biomarker	Sarcoma	gemcitabine + vinorelbine tartrate Sensitive: A2 - Guideline gemcitabine + vinorelbine tartrate Sensitive : A2	gemcitabine + vinorelbine tartrate Sensitive: A2 - Guideline gemcitabine + vinorelbine tartrate Sensitive : A2
No biomarker	Small Cell Lung Cancer	No biomarker	Small Cell Lung Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Ovarian Cancer	No biomarker	Ovarian Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Salivary Gland Cancer	No biomarker	Salivary Gland Cancer	cisplatin + vinorelbine tartrate Sensitive: A2 - Guideline cisplatin + vinorelbine tartrate Sensitive : A2	cisplatin + vinorelbine tartrate Sensitive: A2 - Guideline cisplatin + vinorelbine tartrate Sensitive : A2
HER-2 negative	HER2 Negative Breast Cancer	HER-2 negative	HER2 Negative Breast Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
BRCA2 mutation	Triple Negative Breast Cancer	BRCA2 mutation	Triple Negative Breast Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
BRCA1 mutation	Triple Negative Breast Cancer	BRCA1 mutation	Triple Negative Breast Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Cervical Cancer	No biomarker	Cervical Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	cyclophosphamide + vinorelbine tartrate Sensitive: A2 - Guideline cyclophosphamide + vinorelbine tartrate Sensitive : A2	cyclophosphamide + vinorelbine tartrate Sensitive: A2 - Guideline cyclophosphamide + vinorelbine tartrate Sensitive : A2
No biomarker	Soft Tissue Sarcoma	No biomarker	Soft Tissue Sarcoma	gemcitabine + vinorelbine tartrate Sensitive: A2 - Guideline gemcitabine + vinorelbine tartrate Sensitive : A2	gemcitabine + vinorelbine tartrate Sensitive: A2 - Guideline gemcitabine + vinorelbine tartrate Sensitive : A2
No biomarker	Sarcoma	No biomarker	Sarcoma	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Kaposi Sarcoma	No biomarker	Kaposi Sarcoma	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Malignant Pleural Mesothelioma	No biomarker	Malignant Pleural Mesothelioma	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Non Small Cell Lung Cancer	No biomarker	Non Small Cell Lung Cancer	cisplatin + vinorelbine tartrate Sensitive: A2 - Guideline cisplatin + vinorelbine tartrate Sensitive : A2	cisplatin + vinorelbine tartrate Sensitive: A2 - Guideline cisplatin + vinorelbine tartrate Sensitive : A2
No biomarker	Mesothelioma	No biomarker	Mesothelioma	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Soft Tissue Sarcoma	No biomarker	Soft Tissue Sarcoma	methotrexate + vinorelbine tartrate Sensitive: A2 - Guideline methotrexate + vinorelbine tartrate Sensitive : A2	methotrexate + vinorelbine tartrate Sensitive: A2 - Guideline methotrexate + vinorelbine tartrate Sensitive : A2
EGFR mutation + CREBBP mutation	Non Small Cell Lung Cancer	EGFR mutation + CREBBP mutation	Non Small Cell Lung Cancer	cisplatin + vinorelbine tartrate Resistant: B - Late Trials cisplatin + vinorelbine tartrate Resistant : B	cisplatin + vinorelbine tartrate Resistant: B - Late Trials cisplatin + vinorelbine tartrate Resistant : B
HER-2 negative	HER2 Negative Breast Cancer	HER-2 negative	HER2 Negative Breast Cancer	capecitabine + vinorelbine tartrate Sensitive: C2 – Inclusion Criteria capecitabine + vinorelbine tartrate Sensitive : C2	capecitabine + vinorelbine tartrate Sensitive: C2 – Inclusion Criteria capecitabine + vinorelbine tartrate Sensitive : C2
HR positive	HER2 Negative Breast Cancer	HR positive	HER2 Negative Breast Cancer	epirubicin + vinorelbine tartrate Sensitive: C3 – Early Trials epirubicin + vinorelbine tartrate Sensitive : C3	epirubicin + vinorelbine tartrate Sensitive: C3 – Early Trials epirubicin + vinorelbine tartrate Sensitive : C3
UNC13D mutation	HER2 Negative Breast Cancer	UNC13D mutation	HER2 Negative Breast Cancer	epirubicin + vinorelbine tartrate Sensitive: C3 – Early Trials epirubicin + vinorelbine tartrate Sensitive : C3	epirubicin + vinorelbine tartrate Sensitive: C3 – Early Trials epirubicin + vinorelbine tartrate Sensitive : C3
BIRC5 rs8073069	Non Small Cell Lung Cancer	BIRC5 rs8073069	Non Small Cell Lung Cancer	cisplatin + vinorelbine tartrate Sensitive: C3 – Early Trials cisplatin + vinorelbine tartrate Sensitive : C3	cisplatin + vinorelbine tartrate Sensitive: C3 – Early Trials cisplatin + vinorelbine tartrate Sensitive : C3
SERPINH1 overexpression	Lung Adenocarcinoma	SERPINH1 overexpression	Lung Adenocarcinoma	vinorelbine tartrate Sensitive: D – Preclinical vinorelbine tartrate Sensitive : D	vinorelbine tartrate Sensitive: D – Preclinical vinorelbine tartrate Sensitive : D

vinorelbine tartrate

Associations
(25)

Associations
(25)

vinorelbine tartrate

Associations(25)

Associations(25)

Associations
(25)

Associations
(25)